US healthcare company CVS Health Corporation (NYSE: CVS) announced on Monday that its board of directors has approved a quarterly dividend of sixty-six and one-half cents (USD0.665) per share on the Common Stock of the Corporation.
The dividend is payable on 1 August 2025, to holders of record on 22 July 2025.
According to CVS Health, as of 31 March 2025 it has more than 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a pharmacy benefits manager with approximately 88 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government